Figure 9.
Receiver operating characteristic curves for 3-indoleacetic acid, indoleacetic acid, L-carnitine, and pyroglutamic acid in the non-alcoholic steatohepatitis and non-alcoholic fatty liver disease groups. NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis.